Table 3

Significant univariate Cox proportional survival analysis according to the main variables for the SCD end point

HR95% CIp ValuesC index
FH-SCD3.0281.265 to 7.2520.0130.590
NVST3.1251.380 to 7.0810.0060.626
ABPRE*2.3271.003 to 5.3990.0490.576
MWT >30 mm3.4391.366 to 8.6530.0090.552
LVEF, %*†0.9350.892 to 0.9790.0040.625
MWT, mm†1.0951.020 to 1.1750.0120.564
LAd, mm†1.0591.007 to 1.1130.0260.663
2011 ACCF/AHA guidelines score4.8262.082 to 11.1900.0000.665
2014 ESC guidelines score1.1891.096 to 1.2900.0000.687
ΔSBP, mm Hg0.9810.964 to 0.9980.0280.618
Peak HR, % of predicted*†0.9670.958 to 0.9820.0000.612
VO2AT, mL/kg/min0.8220.719 to 0.9390.0040.697
VO2AT, % of peak VO2 predicted0.9560.925 to 0.9960.0310.646
Peak VO2, mL/kg/min0.9120.847 to 0.9810.0140.635
Peak VO2, % of predicted*†0.9620.934 to 0.9860.0020.647
CP, mL/kg×mm Hg0.9990.999 to 1.0000.0050.677
CP%, % of predicted×mm Hg*†0.9990.9997 to 0.99990.0010.680
VO2/WL slope, mL/min/W*†0.7500.608 to 0.9250.0070.671
VE/VCO2 slope*†1.0811.038 to 1.1250.0000.691
  • *Variables included into the multivariate model including the 2014 ESC guidelines score (see table 4).

  • †Variables included into the multivariate model including the 2011 ACCF/AHA guidelines score (see table 4).

  • ABPRE, abnormal blood pressure response at exercise; ACCF, American College of Cardiology Foundation; AHA, American Heart Association; AT, anaerobic threshold; CP, circulatory power; FH, family history; HR, heart rate; ESC, European Society of Cardiology; LAd, left atrial diameter; LVEF, left ventricular ejection fraction; MWT, maximum wall thickness; NSVT, non sustained ventricular tachycardia; ΔSBP, difference between peak and resting systolic blood pressures; SCD, sudden cardiac death; VO2, oxygen consumption; VO2/WL slope, relation between VO2 versus work load; VE/VCO2 slope, relation between ventilation versus carbon dioxide production.